123 related articles for article (PubMed ID: 4350512)
1. [Delayed hypersensitivity reactions in patients bearing malignant brain tumors with human tumor cell lines grown in vitro].
Febvre H; Maunoury R; Constans JP; Trouillas P
Int J Cancer; 1972 Jul; 10(1):221-32. PubMed ID: 4350512
[No Abstract] [Full Text] [Related]
2. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
Brooks WH; Netsky MG; Normansell DE; Horwitz DA
J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
[TBL] [Abstract][Full Text] [Related]
3. Common antigen in meningioma-derived cell cultures.
Catalano LW; Harter DH; Hsu KC
Science; 1972 Jan; 175(4018):180-2. PubMed ID: 4332758
[TBL] [Abstract][Full Text] [Related]
4. [Demonstration, by means of allogenic antigens, of an antitumoral immunity with cellular mediation in humans].
Febvre H; Moutte A; Constans JP
C R Acad Hebd Seances Acad Sci D; 1972 Nov; 275(19):2191-4. PubMed ID: 4346143
[No Abstract] [Full Text] [Related]
5. Primary brain tumors: tumor immunity and immunocompetence.
Mavligit GM; Gutterman JU; Hersh EM
Surg Neurol; 1973 Sep; 1(5):261-3. PubMed ID: 4353433
[No Abstract] [Full Text] [Related]
6. Cell-bound antiglial immunity in patients with malignant tumors of the brain.
Wahlström T; Saksela E; Troupp H
Cell Immunol; 1973 Feb; 6(2):161-70. PubMed ID: 4348395
[No Abstract] [Full Text] [Related]
7. Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas.
Eggers AE
Neurology; 1972 Mar; 22(3):246-50. PubMed ID: 4334554
[No Abstract] [Full Text] [Related]
8. Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.
Morton DL; Eilber FR; Malmgren RA
Prog Exp Tumor Res; 1971; 14():25-42. PubMed ID: 5002728
[No Abstract] [Full Text] [Related]
9. In vitro demonstration of cell-mediated immunity to human brain tumors.
Levy NL; Mahaley MS; Day ED
Cancer Res; 1972 Mar; 32(3):477-82. PubMed ID: 4334410
[No Abstract] [Full Text] [Related]
10. Tumoural antigens on experimental and human glioblastoma.
Roda JE; Heredero JJ; Villarejo FJ; Roda JM
Acta Neurochir (Wien); 1980; 53(3-4):187-204. PubMed ID: 6999846
[TBL] [Abstract][Full Text] [Related]
11. Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.
Mahaley MS; Brooks WH; Roszman TL; Bigner DD; Dudka L; Richardson S
J Neurosurg; 1977 Apr; 46(4):467-76. PubMed ID: 191575
[TBL] [Abstract][Full Text] [Related]
12. [Immunology and immunotherapy of cerebral tumors. Current status].
Trouillas P
Rev Neurol (Paris); 1973 Jan; 128(1):23-38. PubMed ID: 4367367
[No Abstract] [Full Text] [Related]
13. Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient.
Hitchcock MH; Hollinshead AC; Chretien P; Rizzoli HV
Cancer; 1977 Aug; 40(2):660-6. PubMed ID: 196738
[TBL] [Abstract][Full Text] [Related]
14. Tumor-specific membrane antigens in established cell lines from gliomas.
Wahlström T; Linder E; Saksela E; Westermark B
Cancer; 1974 Aug; 34(2):274-9. PubMed ID: 4369403
[No Abstract] [Full Text] [Related]
15. Proceedings: Immunological investigations on human brain tumor patients.
Mahaley MS
Proc Natl Cancer Conf; 1972; 7():811-5. PubMed ID: 4358071
[No Abstract] [Full Text] [Related]
16. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
Levy NL
J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
[No Abstract] [Full Text] [Related]
17. Common avian oncornavirus-induced tumor antigens in different species as revealed by immuno-ferritin techniques.
Gelderblom H; Bauer H
Int J Cancer; 1973 Mar; 11(2):466-72. PubMed ID: 4133580
[No Abstract] [Full Text] [Related]
18. Malignant and transforming activity of Rous sarcoma virus (RSV). 3. Detection of tumor-specific transplantation and membrane antigens in mouse cell lines transformed in vitro by RSV.
Kryukova IN; Babkova OV; Obukh IB
J Natl Cancer Inst; 1971 Oct; 47(4):819-27. PubMed ID: 4328951
[No Abstract] [Full Text] [Related]
19. Evaluation of the humoral response of meningioma patients to possible common tumour-associated antigens.
Mottet S; Martin-Achard A; de Tribolet N; Diserens AC
Acta Neurochir (Wien); 1980; 52(1-2):19-25. PubMed ID: 7376941
[TBL] [Abstract][Full Text] [Related]
20. [Immunological study of cerebral tumors in vitro].
Febvre H; Maunoury R; Constans JP
Neurochirurgie; 1971; 17(3):203-7. PubMed ID: 4330107
[No Abstract] [Full Text] [Related]
[Next] [New Search]
